{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:38:48Z","timestamp":1778888328402,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T00:00:00Z","timestamp":1614729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0025\/0019"],"award-info":[{"award-number":["RD16\/0025\/0019"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT17\/0015\/0042"],"award-info":[{"award-number":["PT17\/0015\/0042"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01863"],"award-info":[{"award-number":["PI16\/01863"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01638"],"award-info":[{"award-number":["PI19\/01638"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CIBER-BBN"],"award-info":[{"award-number":["CIBER-BBN"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01115"],"award-info":[{"award-number":["PI17\/01115"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["B2017\/BMD-3703"],"award-info":[{"award-number":["B2017\/BMD-3703"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PEJ-2018-TL\/BMD-11529"],"award-info":[{"award-number":["PEJ-2018-TL\/BMD-11529"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PEJD-2019-PRE\/IND-16567"],"award-info":[{"award-number":["PEJD-2019-PRE\/IND-16567"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PENTA FOUNDATION","award":["EPIICAL Project"],"award-info":[{"award-number":["EPIICAL Project"]}]},{"DOI":"10.13039\/501100014365","name":"IISGM","doi-asserted-by":"crossref","award":["COV20\/MAM-BIS"],"award-info":[{"award-number":["COV20\/MAM-BIS"]}],"id":[{"id":"10.13039\/501100014365","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["NAWA International Academic Partnership Programme"],"award-info":[{"award-number":["NAWA International Academic Partnership Programme"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["OST Action CA 17140 \"Cancer Nanomedicine from the Bench to the Bedside\""],"award-info":[{"award-number":["OST Action CA 17140 \"Cancer Nanomedicine from the Bench to the Bedside\""]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human cytomegalovirus (HCMV) is a worldwide infection, causing different troublesome in immunosupressed patients and very related to Human Immunodeficiency Virus 1 (HIV-1) infection, mainly in developing countries, with a co-infection rate of 80% in Africa. The high cost of present treatments and the lack of routinely tests in these countries urge the necessity to develop new molecules or strategies against HCMV. The new treatments should be low-cost and capable of avoiding the emerging problem of resistant virus. Nanoparticles play an important role in several viral infections. Our main focus is to study the potential activity of polyanionic carbosilane dendrimers (PDC), which are hyperbranched molecules with several sulfonate or sulfate groups in their periphery, against different viruses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We studied the activity of G1-S4, G2-S16 and G2-S24P PDCs in MRC-5 cell line against HCMV infection by several plaque reduction assays. Our results show that dendrimers present good biocompatibility at the concentrations tested (1\u201350 \u00b5M) for 6 days in cell culture. Interestingly, both G2-S16 and G2-S24P showed a remarked inhibition at 10 \u00b5M against HCMV infection. Results on attachment and virucidal assays indicated that the inhibition was not directed to the virus or the virus-cell attachment. However, results of time of addition, showed a longer lasting activity of these dendrimers in comparison to ganciclovir, and the combination of G2-S16 or G2-S24P with ganciclovir increases the HCMV inhibition around 90\u2009%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Nanotechnology, in particular polyanionic carbosilane dendrimers, have proved their potential application against HCMV, being capable of inhibiting the infection by themselves or enhancing the activity of ganciclovir, the actual treatment. These compounds represent a low-cost approach to fight HCMV infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-021-00809-4","type":"journal-article","created":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T09:06:19Z","timestamp":1614762379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents"],"prefix":"10.1186","volume":"19","author":[{"given":"I.","family":"Rela\u00f1o-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Espinar-Buitrago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mart\u00edn-Ca\u00f1adilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"G\u00f3mez-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-4500","authenticated-orcid":false,"given":"M. A.","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,3]]},"reference":[{"issue":"6","key":"809_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000322141","volume":"37","author":"V Schottstedt","year":"2010","unstructured":"Schottstedt V, Blumel J, Burger R, Drosten C, Groner A, Gurtler L, et al. Human Cytomegalovirus (HCMV) - Revised. Transfus Med Hemother. 2010;37(6):365\u201375.","journal-title":"Transfus Med Hemother"},{"key":"809_CR2","first-page":"63","volume":"325","author":"C Sinzger","year":"2008","unstructured":"Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 2008;325:63\u201383.","journal-title":"Curr Top Microbiol Immunol"},{"key":"809_CR3","doi-asserted-by":"crossref","unstructured":"Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev. 2000;13(1):83\u2013121","DOI":"10.1128\/CMR.13.1.83"},{"issue":"1","key":"809_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The \u201csilent\u201d global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86\u2013102.","journal-title":"Clin Microbiol Rev"},{"key":"809_CR5","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fmicb.2015.01016","volume":"6","author":"E Adland","year":"2015","unstructured":"Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease and mortality from HIV\/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol. 2015;6:1016.","journal-title":"Front Microbiol"},{"issue":"3","key":"809_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S2055-6640(20)30456-8","volume":"2","author":"M Bates","year":"2016","unstructured":"Bates M, Brantsaeter AB. Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen. J Virus Erad. 2016;2(3):136\u201342.","journal-title":"J Virus Erad"},{"issue":"2","key":"809_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.transproceed.2017.09.058","volume":"50","author":"M Cintra-Cabrera","year":"2018","unstructured":"Cintra-Cabrera M, Suarez-Benjumea A, Bernal-Blanco G, Gonzalez-Roncero FM, Toapanta-Gaibor NG, Suner-Poblet M, et al. Resistant cytomegalovirus infection after renal transplantation: literature review. Transplant Proc. 2018;50(2):575\u20137.","journal-title":"Transplant Proc"},{"issue":"2","key":"809_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/TP.0b013e31821fad25","volume":"92","author":"HA Myhre","year":"2011","unstructured":"Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, et al. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients. Transplantation. 2011;92(2):217\u201323.","journal-title":"Transplantation"},{"issue":"10","key":"809_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/phar.1987","volume":"37","author":"KE Rolling","year":"2017","unstructured":"Rolling KE, Jorgenson MR, Descourouez JL, Mandelbrot DA, Redfield RR, Smith JA. Ganciclovir-resistant cytomegalovirus infection in abdominal solid organ transplant recipients: case series and review of the literature. Pharmacotherapy. 2017;37(10):1258\u201371.","journal-title":"Pharmacotherapy"},{"issue":"44","key":"809_CR10","doi-asserted-by":"publisher","first-page":"17263","DOI":"10.1039\/C7NR05859D","volume":"9","author":"C Guerrero-Beltran","year":"2017","unstructured":"Guerrero-Beltran C, Cena-Diez R, Sepulveda-Crespo D, De la Mata J, Gomez R, Leal M, et al. Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2\/HIV-1 co-infection. Nanoscale. 2017;9(44):17263\u201373.","journal-title":"Nanoscale"},{"issue":"1","key":"809_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/med.21405","volume":"37","author":"D Sepulveda-Crespo","year":"2017","unstructured":"Sepulveda-Crespo D, Cena-Diez R, Jimenez JL, Angeles M-F. Mechanistic studies of viral entry: an overview of dendrimer-based microbicides as entry inhibitors against both HIV and HSV-2 overlapped infections. Med Res Rev. 2017;37(1):149\u201379.","journal-title":"Med Res Rev"},{"key":"809_CR12","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2217\/nnm-2016-0095","volume":"11","author":"R Cena-Diez","year":"2016","unstructured":"Cena-Diez R, Vacas-Cordoba E, Garcia-Broncano P, de la Mata FJ, Gomez R, Maly M, et al. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action. Int J Nanomed. 2016;11:2147\u201362.","journal-title":"Int J Nanomed"},{"issue":"5","key":"809_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/acs.bioconjchem.8b00106","volume":"29","author":"C Guerrero-Beltran","year":"2018","unstructured":"Guerrero-Beltran C, Rodriguez-Izquierdo I, Serramia MJ, Araya-Duran I, Marquez-Miranda V, Gomez R, et al. Anionic carbosilane dendrimers destabilize the GP120-CD4 complex blocking HIV-1 entry and cell to cell fusion. Bioconjug Chem. 2018;29(5):1584\u201394.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"809_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.nano.2016.08.018","volume":"13","author":"D Sepulveda-Crespo","year":"2017","unstructured":"Sepulveda-Crespo D, Jimenez JL, Gomez R, De La Mata FJ, Majano PL, Munoz-Fernandez MA, et al. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture. Nanomedicine. 2017;13(1):49\u201358.","journal-title":"Nanomedicine"},{"issue":"4","key":"809_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.nano.2017.02.007","volume":"13","author":"MA Kamaleddin","year":"2017","unstructured":"Kamaleddin MA. Nano-ophthalmology: applications and considerations. Nanomedicine. 2017;13(4):1459\u201372.","journal-title":"Nanomedicine"},{"issue":"5","key":"809_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2174\/0929867323666161014124008","volume":"24","author":"AG Dumanli","year":"2017","unstructured":"Dumanli AG. Nanocellulose and its composites for biomedical applications. Curr Med Chem. 2017;24(5):512\u201328.","journal-title":"Curr Med Chem"},{"issue":"2","key":"809_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine. 2015;11(2):313\u201327.","journal-title":"Nanomedicine"},{"issue":"5","key":"809_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1182\/bloodadvances.2016000638","volume":"1","author":"AKL Cheung","year":"2017","unstructured":"Cheung AKL, Huang Y, Kwok HY, Chen M, Chen Z. Latent human cytomegalovirus enhances HIV-1 infection in CD34(+) progenitor cells. Blood Adv. 2017;1(5):306\u201318.","journal-title":"Blood Adv"},{"issue":"9","key":"809_CR19","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/infdis\/jiy327","volume":"218","author":"EL Johnson","year":"2018","unstructured":"Johnson EL, Boggavarapu S, Johnson ES, Lal AA, Agrawal P, Bhaumik SK, et al. Human cytomegalovirus enhances placental susceptibility and replication of human immunodeficiency virus type 1 (HIV-1), which may facilitate in utero HIV-1 transmission. J Infect Dis. 2018;218(9):1464\u201373.","journal-title":"J Infect Dis"},{"issue":"2","key":"809_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.earlhumdev.2012.08.008","volume":"89","author":"A Mania","year":"2013","unstructured":"Mania A, Kemnitz P, Cudnoch K, Mazur-Melewska K, Figlerowicz M, Sluzewski W. Clinical condition and transmission of coinfections with human cytomegalovirus in infants of HIV-1 infected mothers in the era of mother-to-child-transmission prophylaxis. Early Hum Dev. 2013;89(2):119\u201324.","journal-title":"Early Hum Dev"},{"issue":"34","key":"809_CR21","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1039\/D0RA03448G","volume":"10","author":"C Guti\u00e9rrez-Ulloa","year":"2020","unstructured":"Guti\u00e9rrez-Ulloa C, Pe\u00f1a-Gonz\u00e1lez CE, Barrios-Gumiel A, Ce\u00f1a-D\u00edez R, Serram\u00eda-Lobera MJ, Mu\u00f1oz-Fern\u00e1ndez M\u00c1, et al. New synthetic procedure for the antiviral sulfonate carbosilane dendrimer G2\u2013S16 and its fluorescein-labelled derivative for biological studies. RSC Adv. 2020;10(34):20083\u20138.","journal-title":"RSC Adv"},{"issue":"41","key":"809_CR22","doi-asserted-by":"publisher","first-page":"12733","DOI":"10.1039\/c2dt31099f","volume":"41","author":"B Rasines","year":"2012","unstructured":"Rasines B, Sanchez-Nieves J, Maiolo M, Maly M, Chonco L, Jimenez JL, et al. Synthesis, structure and molecular modelling of anionic carbosilane dendrimers. Dalton Trans. 2012;41(41):12733\u201348.","journal-title":"Dalton Trans"},{"issue":"8","key":"809_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/pola.27090","volume":"52","author":"E Arn\u00e1iz","year":"2014","unstructured":"Arn\u00e1iz E, Vacas-C\u00f3rdoba E, Gal\u00e1n M, Pion M, G\u00f3mez R, Mu\u00f1oz-Fern\u00e1ndez M\u00c1, et al. Synthesis of anionic carbosilane dendrimers via \u201cclick chemistry\u201d and their antiviral properties against HIV. J Polym Sci, Part A: Polym Chem. 2014;52(8):1099\u2013112.","journal-title":"J Polym Sci, Part A: Polym Chem"},{"issue":"2","key":"809_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gene.2015.08.009","volume":"574","author":"AA Stepanenko","year":"2015","unstructured":"Stepanenko AA, Dmitrenko VV. Pitfalls of the MTT assay: direct and off-target effects of inhibitors can result in over\/underestimation of cell viability. Gene. 2015;574(2):193\u2013203.","journal-title":"Gene"},{"key":"809_CR25","doi-asserted-by":"crossref","unstructured":"Rodriguez-Izquierdo I, Natalia C, Garcia F, Munoz-Fernandez M. G2-S16 sulfonate dendrimer as new therapy for treatment failure in HIV-1 entry inhibitors. Nanomedicine (Lond). 2019;14(9):1095\u2013107.","DOI":"10.2217\/nnm-2018-0364"},{"key":"809_CR26","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.2147\/IJN.S188495","volume":"14","author":"R Cena-Diez","year":"2019","unstructured":"Cena-Diez R, Martin-Moreno A, de la Mata FJ, Gomez-Ramirez R, Munoz E, Ardoy M, et al. G1\u2013S4 or G2\u2013S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity. Int J Nanomed. 2019;14:2371\u201381.","journal-title":"Int J Nanomed"},{"key":"809_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.podrm.2017.12.001","volume":"43","author":"AA Al-Badr","year":"2018","unstructured":"Al-Badr AA, Ajarim TDS. Ganciclovir. Profiles Drug Subst Excip Relat Methodol. 2018;43:1\u2013208.","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"issue":"2","key":"809_CR28","doi-asserted-by":"publisher","first-page":"e00029","DOI":"10.1128\/mBio.00029-16","volume":"7","author":"S Karniely","year":"2016","unstructured":"Karniely S, Weekes MP, Antrobus R, Rorbach J, van Haute L, Umrania Y, et al. Human cytomegalovirus infection upregulates the mitochondrial transcription and translation machineries. MBio. 2016;7(2):e00029.","journal-title":"MBio"},{"issue":"8","key":"809_CR29","doi-asserted-by":"publisher","first-page":"E1528","DOI":"10.1073\/pnas.1614268114","volume":"114","author":"A Vysochan","year":"2017","unstructured":"Vysochan A, Sengupta A, Weljie AM, Alwine JC, Yu Y. ACSS2-mediated acetyl-CoA synthesis from acetate is necessary for human cytomegalovirus infection. Proc Natl Acad Sci USA. 2017;114(8):E1528\u201335.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00809-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-021-00809-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-00809-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T09:06:42Z","timestamp":1614762402000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-00809-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-00809-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,3]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}